— Know what they know.
Not Investment Advice

NAOV NASDAQ

NanoVibronix, Inc.
1W: +34.3% 1M: +30.0% 3M: -32.9% YTD: +32.6% 1Y: -93.5% 3Y: -99.5% 5Y: -99.9%
$1.90
Last traded 2026-02-09 — delisted
NASDAQ · Healthcare · Medical - Devices · $1.5M mcap · 796918 float · 10.82% daily turnover · Short 31% of daily vol

Balance Sheet Trends

Total Assets
$4M -45.6% ▼
5Y CAGR: +12.3%
Total Liabilities
$3M +11.8% ▲
5Y CAGR: +34.3%
Shareholders Equity
$627K -84.3% ▼
5Y CAGR: -14.2%
Cash & Investments
$752K -77.1% ▼
5Y CAGR: -10.9%
Total Debt
$116K +2220.0% ▲
Net Debt
-$636K +80.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$7M$8M$3M$3M$752K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$7M$8M$3M$3M$752K
Net Receivables$93K$200K$109K$425K$268K
Inventory$145K$175K$2M$3M$2M
Other Current Assets$391K$64K$0$0$98K
Total Current Assets$8M$8M$6M$6M$3M
Property, Plant & Equip.$35K$54K$88K$12K$125K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$19K$3K$1K$0
Other Non-Current Assets$224K$207K$179K$174K$173K
Total Non-Current Assets$259K$280K$270K$187K$298K
Total Assets$8M$9M$6M$7M$4M
— Liabilities —
Accounts Payable$144K$87K$66K$138K$47K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$21K$46K$15K
Other Current Liabilities$2M$2M$2M$2M$47K
Total Current Liabilities$3M$2M$2M$2M$3M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$3M$406K$223K$217K$216K
Total Non-Current Liabilities$3M$406K$330K$232K$280K
Total Liabilities$6M$2M$3M$3M$3M
— Equity —
Common Stock$22K$1K$2K$2K$3K
Retained Earnings-$43M-$57M-$62M-$66M-$70M
Accumulated OCI$66K$60K-$18K-$67K-$80K
Total Stockholders Equity$2M$6M$3M$4M$627K
Total Liabilities & Equity$8M$9M$6M$7M$4M
— Key Metrics —
Total Debt$31K$49K$81K$5K$116K
Net Debt-$7M-$8M-$3M-$3M-$636K
Total Investments$0$19K$3K$1K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms